[Correlation between the biofilm-forming ability, biofilm-related genes and antimicrobial resistance of Acinetobacter baumannii]
- PMID: 25230865
- DOI: 10.3760/cma.j.issn.2095-4352.2014.09.007
[Correlation between the biofilm-forming ability, biofilm-related genes and antimicrobial resistance of Acinetobacter baumannii]
Abstract
Objective: To study the biofilm-forming ability and the distribution of biofilm-related genes in Acinetobacter baumannii clinical isolates as well as antimicrobial resistance, to analyze their relationships with the bacterial resistance phenotype.
Methods: A prospective study was conducted. Biofilm models of 70 strains Acinetobacter baumannii collected in Chengwu County People's Hospital from October 2012 to October 2013 were constructed using 96-well polystyrene plate. In order to analyze the biofilm-forming ability, a qualitative and quantitative analysis was conduct by crystal violet staining assay. And the antimicrobial resistance of different biofilm-forming ability strains was compared including imipenem, amikacin, meropenem, cefepime, sulbactam cefoperazone, trimethoprim, levofloxacin, gentamicin, ciprofloxacin, cefotaxime, ceftizoxime, aztreonam, piperacillin, ceftriaxone, cefuroxime. In addition, the expressions of biofilm-related gene Bap, bfs and intI1 were tested with polymerase chain reaction (PCR) assay.
Results: Among 70 strains Acinetobacter baumannii, 40 strains were multi-drug resistant (57.14%) and 6 strains were pan-drug resistant (8.57%); 68 strains had biofilm-forming ability (97.14%), 14 of which were weakly positive, 20 were positive and 34 were strongly positive. The antimicrobial resistant rate of Acinetobacter baumannii to imipenem, amikacin, meropenem and cefepime was decreased, it was 30.00%, 32.86%, 38.57% and 41.43%, respectively. However, the antimicrobial resistant rates to other commonly used antibiotics were all higher than 50%. The drug resistance of Acinetobacter baumannii to levofloxacin (85.71%, 45.00%, 38.24%, χ² = 9.225, P=0.010), cefepime (71.43%, 45.00%, 29.41%, χ² = 7.222, P=0.027), gentamicin (78.57%, 55.00%, 38.24%, χ² = 6.601, P=0.037) was significantly decreased when biofilm-forming ability reinforced (weakly positive, positive, hadropositive). Bap gene positive rate of weakly positive, positive and strong positive biofilm-forming strains Acinetobacter baumannii was 50.00%, 65.00% and 79.41% (χ² = 4.244, P=0.120), respectively. Bfs gene positive rate was 35.71%, 65.00% and 88.24% , respectively (χ² = 13.602, P=0.001) and intI1 gene positive rate was 42.86%, 75.00% and 91.18%, respectively (χ² = 12.902, P=0.002). Moreover, the antimicrobial resistances of biofilm-related gene positive strains were higher than the negative, of which the drug resistance of intI1 positive group to amikacin was significantly higher than the negative group (40.38% vs. 11.11%, χ² = 5.194, P=0.023).
Conclusions: The Acinetobacter baumannii collected from the hospital had strong multi-drug resistance as well as strong biofilm-forming ability. The drug resistance of Acinetobacter baumannii decreased when biofilm-forming ability reinforced. In addition, genes, such as Bap, bfs, and intI1, contributed to biofilm formation.
Similar articles
-
Convergence of Biofilm Formation and Antibiotic Resistance in Acinetobacter baumannii Infection.Front Med (Lausanne). 2022 Mar 24;9:793615. doi: 10.3389/fmed.2022.793615. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35402433 Free PMC article. Review.
-
[Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].Zhonghua Shao Shang Za Zhi. 2014 Apr;30(2):166-70. Zhonghua Shao Shang Za Zhi. 2014. PMID: 24989663 Chinese.
-
Prevalence and Characterization of Integrons in Multidrug Resistant Acinetobacter baumannii in Eastern China: A Multiple-Hospital Study.Int J Environ Res Public Health. 2015 Aug 21;12(8):10093-105. doi: 10.3390/ijerph120810093. Int J Environ Res Public Health. 2015. PMID: 26308028 Free PMC article.
-
Analysis of virulence phenotypes and antibiotic resistance in clinical strains of Acinetobacter baumannii isolated in Nashville, Tennessee.BMC Microbiol. 2021 Jan 9;21(1):21. doi: 10.1186/s12866-020-02082-1. BMC Microbiol. 2021. PMID: 33422000 Free PMC article.
-
Co-regulation of biofilm formation and antimicrobial resistance in Acinetobacter baumannii: from mechanisms to therapeutic strategies.Eur J Clin Microbiol Infect Dis. 2023 Dec;42(12):1405-1423. doi: 10.1007/s10096-023-04677-8. Epub 2023 Oct 28. Eur J Clin Microbiol Infect Dis. 2023. PMID: 37897520 Free PMC article. Review.
Cited by
-
In vitro evaluation of the antimicrobial activity of antiseptics against clinical Acinetobacter baumannii strains isolated from combat wounds.Front Microbiol. 2022 Oct 4;13:932467. doi: 10.3389/fmicb.2022.932467. eCollection 2022. Front Microbiol. 2022. PMID: 36267170 Free PMC article.
-
Convergence of Biofilm Formation and Antibiotic Resistance in Acinetobacter baumannii Infection.Front Med (Lausanne). 2022 Mar 24;9:793615. doi: 10.3389/fmed.2022.793615. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35402433 Free PMC article. Review.
-
Insights Into Mechanisms of Biofilm Formation in Acinetobacter baumannii and Implications for Uropathogenesis.Front Cell Infect Microbiol. 2020 May 29;10:253. doi: 10.3389/fcimb.2020.00253. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 32547965 Free PMC article. Review.
-
Investigation of biofilm production and its association with genetic and phenotypic characteristics of OM (osteomyelitis) and non-OM orthopedic Staphylococcus aureus.Ann Clin Microbiol Antimicrob. 2020 Mar 26;19(1):10. doi: 10.1186/s12941-020-00352-4. Ann Clin Microbiol Antimicrob. 2020. PMID: 32220258 Free PMC article.
-
Quorum-Sensing Regulation of Antimicrobial Resistance in Bacteria.Microorganisms. 2020 Mar 17;8(3):425. doi: 10.3390/microorganisms8030425. Microorganisms. 2020. PMID: 32192182 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Medical